12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Healthcare stocks experienced significant movements in Wednesday's intraday session, with notable gainers including CytomX Therapeutics and Surmodics following their earnings reports, and losers like CVRx and CVS Health also reacting to their earnings releases. The movements reflect a mix of positive and negative reactions to company earnings and other market factors.
May 01, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CVRx stock declined by 36.9% to $9.79, with a market cap of $211.4 million, after its Q1 earnings were released.
The decline in CVRx's stock price suggests a negative market reaction to its Q1 earnings report, possibly due to disappointing performance or outlook.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
CVS Health stock fell 16.94% to $56.24, with a market cap of $70.8 billion, following its Q1 earnings announcement.
CVS Health's stock price drop is likely due to a negative reaction to its Q1 earnings, indicating concerns over its financial results or future guidance.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
CytomX Therapeutics stock surged 154.6% to $4.15, with a market cap of $281.0 million, reflecting a strong positive reaction to its earnings report.
The significant surge in CTMX's stock price is likely due to a positive earnings report, indicating strong performance or outlook that has positively influenced investor sentiment.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Surmodics shares increased by 30.14% to $33.44, with a market cap of $475.9 million, following the release of its Q2 earnings report.
Surmodics' stock price increase is directly tied to its Q2 earnings report, suggesting the market has reacted positively to its financial performance or future outlook.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90